Yield10 Bioscience, Inc.
YTEN · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -86.7% | -26.7% | -23.2% | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | -383.3% | -45.8% | 5.9% | -553.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -23,545% | -2,930.7% | -1,868.4% | -1,179.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -24,091.7% | -3,014.7% | -1,796.6% | -1,277.3% |
| EPS Diluted | -43.66 | -66.25 | -55.95 | -103.21 |
| % Growth | 34.1% | -18.4% | 45.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |